Results 301 to 310 of about 760,497 (383)

Gut microbiota‐related modulation of immune mechanisms in post‐infarction remodelling and heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 942-954, April 2025.
Abstract The immune system has long been recognized as a key driver in the progression of heart failure (HF). However, clinical trials targeting immune effectors have consistently failed to improve patient outcome across different HF aetiologies. The activation of the immune system in HF is complex, involving a broad network of pro‐inflammatory and ...
Johann Roessler, Friederike Zimmermann, Bettina Heidecker, Ulf Landmesser, Arash Haghikia   +4 more
wiley   +1 more source

LARP1 acts as a key mediator in preventing angiotensin II-induced cardiac dysfunction and fibrosis. [PDF]

Cell Biosci
Zheng H, Yang C.
europepmc   +1 more source

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya, Toru Kubo, Jin Endo, Seiji Takashio, Masatoshi Minamisawa, Jun Hamada, Tomonori Ishii, Hajime Abe, Hiroaki Konishi, Kenichi Tsujita   +9 more
wiley   +1 more source

Does tenodesis of tensor fascia latae with hip abductors after proximal femoral resection and modular endoprosthetic reconstruction lead to functional improvements? [PDF]

J Exp Orthop
Lavoie-Hudon A, Cloutier JP, Dion N, Laurendeau S, Corbeil P, Arteau A.   +5 more
europepmc   +1 more source

Single‐nucleus RNA sequencing reveals RUNX1 regulation of muscle hypertrophy through PI3K/AKT/mTOR pathway [PDF]

Chenxu Wang, Junjie Ma, Yibin Wang, Rui Liu, Chenxi Zhang, Qingyuan Li, Lixin Zhang, Qihang Hou, Xiao-Jun Yang   +8 more
openalex   +1 more source

Physiological adaptations and practical efficacy of different blood flow restriction resistance training modes in athletic populations. [PDF]

Front Physiol
He C, Zhu D, Hu Y.
europepmc   +1 more source

Commonalities of platelet dysfunction in heart failure with preserved ejection fraction and underlying comorbidities

ESC Heart Failure, Volume 12, Issue 2, Page 1013-1028, April 2025.
Abstract Heart failure with preserved ejection fraction (HFpEF) is characterized by a lack of a specific targeted treatment and a complex, partially unexplored pathophysiology. Common comorbidities associated with HFpEF are hypertension, atrial fibrillation, obesity and diabetes.
Giorgia D'Italia, Blanche Schroen, Judith M.E.M. Cosemans   +2 more
wiley   +1 more source

Prevalence of Sleep-related Breathing Disorders in Children and Its Correlation with Oral Health Status Using FAIREST-6: Cross-sectional Study. [PDF]

Int J Clin Pediatr Dent
Shirsat SM, Pawar M, Choudhari KS, Panamgipalli S, Mathawala V, Patil S.   +5 more
europepmc   +1 more source

Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

ESC Heart Failure, Volume 12, Issue 2, Page 1029-1044, April 2025.
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo, Tor Biering‐Sorensen, Joao P. Ferreira, Carlo Mario Lombardi, Andrea Bonelli, Andrea Garascia, Marco Metra, Riccardo M. Inciardi   +7 more
wiley   +1 more source

ROS produced by Dual oxidase regulate cell proliferation and haemocyte migration during leg regeneration in the cricket. [PDF]

Development
Okumura-Hirono M, Bando T, Hamada Y, Araki M, Ohuchi H.   +4 more
europepmc   +1 more source